Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
PAAB Forum Quarterly Review - Q1/2024
-
Happy Wednesday @Manufacturer @Agency
The PAAB Forum Quarterly Review giving a run down of the activities at PAAB over the last quarter, has been posted.
Please pop comments and questions in the chat below.
Have a great week.
